Renasant Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$387K Sell
421
-11
-3% -$11.2K 0.27% 92
2025
Q4
$464K Buy
432
+53
+14% +$50.7K 0.31% 89
2025
Q3
$289K Sell
379
-26
-6% -$19.3K 0.18% 118
2025
Q2
$316K Sell
405
-925
-70% -$719K 0.21% 109
2025
Q1
$1.1M Sell
1,330
-21
-2% -$17.5K 0.73% 41
2024
Q4
$1.04M Sell
1,351
-45
-3% -$37.3K 0.68% 49
2024
Q3
$1.24M Sell
1,396
-368
-21% -$331K 0.81% 35
2024
Q2
$1.6M Sell
1,764
-420
-19% -$336K 1.1% 22
2024
Q1
$1.7M Buy
2,184
+3
+0.1% +$2.13K 1.21% 13
2023
Q4
$1.27M Buy
2,181
+160
+8% +$93.4K 1.01% 22
2023
Q3
$1.09M Buy
2,021
+305
+18% +$157K 0.91% 30
2023
Q2
$805K Sell
1,716
-946
-36% -$397K 0.66% 47
2023
Q1
$914K Sell
2,662
-421
-14% -$142K 0.71% 42
2022
Q4
$1.13M Buy
3,083
+304
+11% +$108K 0.85% 32
2022
Q3
$898K Buy
2,779
+1,165
+72% +$369K 0.79% 37
2022
Q2
$523K Buy
1,614
+565
+54% +$170K 0.43% 74
2022
Q1
$300K Buy
+1,049
New +$270K 0.2% 146

Other funds holding LLY

Renasant Bank's LLY Position: Q1 2026 in Review

Renasant Bank reduced its Eli Lilly (LLY) stake by 2.5% in Q1 2026, selling an estimated $11.2K and leaving 421 shares worth $387K. The position accounts for 0.27% of the portfolio, ranked #92.

Renasant Bank first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.7M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Renasant Bank held 421 shares of Eli Lilly worth $387K as of Q1 2026.
  • Renasant Bank sold 11 Eli Lilly shares in Q1 2026, an estimated $11.2K.
  • Eli Lilly made up 0.27% of Renasant Bank's portfolio in Q1 2026, its #92 holding.
  • Renasant Bank first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
  • Renasant Bank's Eli Lilly position peaked at $1.7M in Q1 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Renasant Bank's 13F filing for Q1 2026, filed 29 Apr 2026.